Churg-Strauss syndrome risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Churg-Strauss syndrome}}
{{Xyz}}
{{CMG}}{{APM}}{{AE}}{{KW}}


{{CMG}}; {{AE}}
==Overview==
==Overview==
The risk factors associated with Eosinophilic granulomatosis with polyangiitis is not clear. However, various triggering factors have been observed and reported. The risk factors that are likely associated with Eosinophilic granulomatosis with polyangiitis include: infectious agents, drugs, desensitization and or vaccinations.<ref name="pmid24530234">{{cite journal| author=Mouthon L, Dunogue B, Guillevin L| title=Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). | journal=J Autoimmun | year= 2014 | volume= 48-49 | issue=  | pages= 99-103 | pmid=24530234 | doi=10.1016/j.jaut.2014.01.018 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24530234  }} </ref>
There are no established risk factors for [disease name].
 
OR
 
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
 
OR
 
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
 
OR
 
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.


==Risk Factors==
==Risk Factors==
The risk factors associated with Eosinophilic granulomatosis with polyangiitis is not clear. However, various triggering factors have been observed and reported. The risk factors that are likely associated with Eosinophilic granulomatosis with polyangiitis include: infectious agents, drugs (freebase cocaine<ref name="pmid8834352">{{cite journal| author=Orriols R, Muñoz X, Ferrer J, Huget P, Morell F| title=Cocaine-induced Churg-Strauss vasculitis. | journal=Eur Respir J | year= 1996 | volume= 9 | issue= 1 | pages= 175-7 | pmid=8834352 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8834352  }}</ref>, macrolides<ref name="pmid9555706">{{cite journal| author=Dietz A, Hübner C, Andrassy K| title=[Macrolide antibiotic-induced vasculitis (Churg-Strauss syndrome)]. | journal=Laryngorhinootologie | year= 1998 | volume= 77 | issue= 2 | pages= 111-4 | pmid=9555706 | doi=10.1055/s-2007-996943 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9555706  }}</ref>, carbamazepine<ref name="pmid2918954">{{cite journal| author=Imai H, Nakamoto Y, Hirokawa M, Akihama T, Miura AB| title=Carbamazepine-induced granulomatous necrotizing angiitis with acute renal failure. | journal=Nephron | year= 1989 | volume= 51 | issue= 3 | pages= 405-8 | pmid=2918954 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2918954  }}</ref>, quinine<ref name="pmid2108777">{{cite journal| author=Mathur S, Dooley J, Scheuer PJ| title=Quinine induced granulomatous hepatitis and vasculitis. | journal=BMJ | year= 1990 | volume= 300 | issue= 6724 | pages= 613 | pmid=2108777 | doi= | pmc=1662381 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2108777  }}</ref>), desensitization and or vaccinations.<ref name="pmid24530234" />
*There are no established risk factors for [disease name].
OR
*The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
 
*Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
===Common Risk Factors===
*Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
*Common risk factors in the development of [disease name] include:
**[Risk factor 1]
**[Risk factor 2]
**[Risk factor 3]
 
===Less Common Risk Factors===
*Less common risk factors in the development of [disease name] include:
**[Risk factor 1]
**[Risk factor 2]
**[Risk factor 3]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Autoimmune diseases]]
[[Category:Rheumatology]]
[[Category:Needs content]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]

Revision as of 22:39, 30 March 2018

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Churg-Strauss syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Churg-Strauss syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Churg-Strauss syndrome risk factors

CDC on Churg-Strauss syndrome risk factors

Churg-Strauss syndrome risk factors in the news

Blogs on Churg-Strauss syndrome risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Churg-Strauss syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Risk Factors

  • There are no established risk factors for [disease name].

OR

  • The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
  • Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Common Risk Factors

  • Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
  • Common risk factors in the development of [disease name] include:
    • [Risk factor 1]
    • [Risk factor 2]
    • [Risk factor 3]

Less Common Risk Factors

  • Less common risk factors in the development of [disease name] include:
    • [Risk factor 1]
    • [Risk factor 2]
    • [Risk factor 3]

References

Template:WH Template:WS